Global Dyspnea Treatment MarketThe global dyspnea treatment market, valued at USD 5.90 billion in 2022, is expected to experience robust growth, projected to reach approximately USD 12.3 billion by ...

Any Australian who has filled a prescription at the chemist will have been asked if they want a branded product or the generic version. And with consumers looking to cut costs wherever they can ...

U.S. researchers have detected microplastic particles in air exhaled by wild bottlenose dolphins, suggesting that inhalation may be a relevant route of exposure to these potentially harmful ...

The Biden administration has reformed Medicare, gone after bogus drug patents and pushed pharmaceutical companies to reduce inhaler costs for patients. “Climate-friendly inhalers” could jeopardize ...

Similarly, AstraZeneca’s blockbuster drug Symbicort is only now facing a generic competitor, nearly 20 years after its 2006 launch. The inhaler has been widely prescribed because it contains a ...

Drug companies are taking advantage ... GlaxoSmithKline produce some of the most widely used inhalers in the United States, including Symbicort and Ventolin. They plan to seek regulatory approval ...

Vaccines are an essential part of global efforts to reduce AMR as they prevent infections, reduce the use and overuse of antimicrobials, and slow the emergence and spread of drug-resistant pathogens.

The list, comprising 101 generic drugs, includes common prescriptions like penicillin, metformin, and lithium, as well as asthma inhalers like albuterol. Notably, these drugs will not require prior ...

in response to President Joe Biden’s executive order to lower prescription drug costs. The CMS has compiled a sample list of 272 medications, including various pills, ointments, capsules and inhalers, ...

The inhaler cleared the FDA’s desk in ... Last August, Viatris and Kindeva Drug Delivery launched the first Symbicort copycat in the U.S. under the brand name Breyna. Breyna is indicated for ...

Dry-powder corticosteroid inhalers, or those designed to have a low impact on climate, are as effective as those based on pressurized, metered doses at reducing the risk of poor outcomes in people ...